Actuate Therapeutics ACTU Drops 409 as Shares Test Critical 200 Support Level Altria MO Holds Near Support Amid Modest Decline Key Levels in Focus Axsome Therapeutics Holds Near Resistance as Biotech Sector Shows Mixed Signals LanzaTech Global LNZA Shares Slide 4 as Selling Pressure Intensifies Key Support Levels Tested